Reaktion #68047
ord-473148dd016b4c6ba71b60824cefb0a1
Reaktionsgleichung
Edukte
Reagenzien
Lösungsmittel
Reaktionsbedingungen
Aufarbeitung
- 1workup.ADDITIONwas added
- 2SonstigeThe solvent was removed under reduced pressure, and aqueous saturated sodium hydrogen carbonate solution and chloroform
- 3workup.ADDITIONwere added
- 4SonstigeThe organic layer was separated
- 5Extraktionthe aqueous layer was extracted with chloroform
- 6Waschenwashed with aqueous saturated sodium chloride solution
- 7Trocknendried over anhydrous magnesium sulfate
- 8Sonstigethe solvent was removed under reduced pressure
- 9SonstigeThe residue thus obtained
- 10Sonstigewas purified by silica gel column chromatography [eluent; chloroform:methanol=10:1]
Vorschrift
To 2 mL of a chloroform solution containing 0.25 g of methyl 1-(2-(4-((tert-butoxycarbonyl)(2,3-dihydro-1,4-benzodioxin-6-ylmethyl)amino)piperidin-1-yl)ethyl)-7-methoxy-2-oxo-1,2-dihydroquinoline-4-carboxylate, 2 mL of trifluoroacetic acid was added and stirred for 16 hours. The solvent was removed under reduced pressure, and aqueous saturated sodium hydrogen carbonate solution and chloroform were added. The organic layer was separated, and the aqueous layer was extracted with chloroform. The organic layer and extracts were combined, washed with aqueous saturated sodium chloride solution, dried over anhydrous magnesium sulfate, and the solvent was removed under reduced pressure. The residue thus obtained was purified by silica gel column chromatography [eluent; chloroform:methanol=10:1] to give 0.12 g of methyl 1-(2-(4-((2,3-dihydro-1,4-benzodioxin-6-ylmethyl)amino)piperidin-1-yl)ethyl)-7-methoxy-2-oxo-1,2-dihydroquinoline-4-carboxylate as a white solid.